Search

Search Constraints

You searched for: Author/Creator Prehn, Jochen

Search Results

1. Abstracts from the 5th International Conference for Healthcare and Medical Students (ICHAMS). Issue 4 (July 2016)

2. Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. Issue 1 (December 2016)

3. Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. Issue 1 (December 2016)

4. Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. Issue 1 (December 2016)

6. Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy. Issue 1 (December 2018)

7. Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. Issue 1 (December 2016)

8. Mixed copper(ii)–phenanthroline complexes induce cell death of ovarian cancer cells by evoking the unfolded protein response. Issue 9 (26th July 2019)

9. MODL-27. PRECLINICAL INTERROGATION OF IMMUNOTHERAPY TREATMENT STRATEGIES IN GLIOBLASTOMA (GBM) USING A CLINICALLY RELEVANT DISEASE MODEL. (14th November 2022)

10. Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711. Issue 11 (November 2018)